154 related articles for article (PubMed ID: 24793349)
1. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study.
Esteghamati A; Hafezi-Nejad N; Sheikhbahaei S; Heidari B; Zandieh A; Ebadi M; Nakhjavani M
J Clin Lipidol; 2014; 8(3):279-86. PubMed ID: 24793349
[TBL] [Abstract][Full Text] [Related]
2. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.
Zabetian A; Hadaegh F; Azizi F
Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
4. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
5. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
6. Dual role of physical workload and occupational noise in the association of the metabolic syndrome with risk of coronary heart disease: findings from the Helsinki Heart Study.
Koskinen HL; Kauppinen T; Tenkanen L
Occup Environ Med; 2011 Sep; 68(9):666-73. PubMed ID: 21148595
[TBL] [Abstract][Full Text] [Related]
7. Is metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunction.
Corona G; Monami M; Rastrelli G; Melani C; Balzi D; Sforza A; Forti G; Mannucci E; Maggi M
J Sex Med; 2011 Feb; 8(2):504-11. PubMed ID: 21091887
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
9. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and incident coronary heart disease in Australian indigenous populations.
Li M; McCulloch B; McDermott R
Obesity (Silver Spring); 2012 Jun; 20(6):1308-12. PubMed ID: 21660075
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients.
Protopsaltis I; Nikolopoulos G; Dimou E; Brestas P; Kokkoris S; Korantzopoulos P; Melidonis A
Atherosclerosis; 2007 Nov; 195(1):189-94. PubMed ID: 17064711
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
Lim HS; Lip GY; Beevers DG; Blann AD
Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
[TBL] [Abstract][Full Text] [Related]
13. Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the tehran lipid and glucose study.
Hadaegh F; Mohebi R; Cheraghi L; Tohidi M; Moghaddam NB; Bozorogmanesh M; Sheikholeslami F; Azizi F
Stroke; 2012 Jun; 43(6):1669-71. PubMed ID: 22382161
[TBL] [Abstract][Full Text] [Related]
14. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and all-cause mortality in older men and women.
Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics.
Telles R; Lanna C; Ferreira G; Ribeiro A
Lupus; 2010 Jun; 19(7):803-9. PubMed ID: 20118159
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein cholesterol and metabolic syndrome in an Iranian high-risk population.
Janghorbani M; Amini M
Diabetes Metab Syndr; 2015; 9(2):91-7. PubMed ID: 25108602
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and its individual components with mortality among patients with coronary heart disease.
Chen Q; Zhang Y; Ding D; Li D; Xia M; Li X; Yang Y; Li Q; Hu G; Ling W
Int J Cardiol; 2016 Dec; 224():8-14. PubMed ID: 27599384
[TBL] [Abstract][Full Text] [Related]
19. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
[TBL] [Abstract][Full Text] [Related]
20. Joint effect of self-reported sleep problems and three components of the metabolic syndrome on risk of coronary heart disease.
Loponen M; Hublin C; Kalimo R; Mänttäri M; Tenkanen L
J Psychosom Res; 2010 Feb; 68(2):149-58. PubMed ID: 20105697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
